Nothing Special   »   [go: up one dir, main page]

CN110078737A - Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof - Google Patents

Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof Download PDF

Info

Publication number
CN110078737A
CN110078737A CN201910507221.0A CN201910507221A CN110078737A CN 110078737 A CN110078737 A CN 110078737A CN 201910507221 A CN201910507221 A CN 201910507221A CN 110078737 A CN110078737 A CN 110078737A
Authority
CN
China
Prior art keywords
compound
preparation
substituted benzimidazole
perfluoroalkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910507221.0A
Other languages
Chinese (zh)
Inventor
陈晓岚
曾繁林
於兵
屈凌波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhengzhou University
Original Assignee
Zhengzhou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhengzhou University filed Critical Zhengzhou University
Priority to CN201910507221.0A priority Critical patent/CN110078737A/en
Publication of CN110078737A publication Critical patent/CN110078737A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof.The present invention is using N- methylacryloyl -2-Phenylbenzimidazole class compound and perfluoroalkyl iodide as raw material, synthesizing perfluoroalkyl substituted benzimidazole and compound of isobioquin group under the action of TMEDA (tetraethyl diamines).This method have the advantages that raw material is cheap and easy to get, reaction condition is mild, it is easy to operate, be easy to amplify, have industrialized production and application prospect.The analog derivative has potential application in research fields such as medicine/organic syntheses, and the present invention provides new method for the synthesis of benzimidazole and compound of isobioquin group.

Description

Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof
Technical field
The present invention relates to the field of chemical synthesis, and in particular to a kind of perfluoroalkyl substituted benzimidazole and isobioquin group Close the preparation method of object.
Background technique
Benzimidazole and compound of isobioquin group are a kind of important skeletons, in biochemistry, pharmaceutical chemistry and material Chemistry etc. has diversified application.Such as it has been applied to anti-inflammatory agent, antidiabetic even antineoplastic etc..Due to Its structural consequences, researcher are to prepare benzimidazole and compound of isobioquin group has made a large amount of effort.Such as I By decarboxylation coupling reaction realize such compound synthesis (Chem. Commun.,2019, 55(19), 2861- 2864.).But the method use the oxidants of silver and equivalent.
Meanwhile it being fluorinated functional group and being increasingly being applied to drug, agrochemical industry and materials science field.By fluorine Change moieties to be introduced into bioactive molecule to its physical chemistry and biological property with profound influence, leads to the parent of enhancing Lipid, bioavilability and metabolic stability.A kind of effective and convenient photocatalysis is disclosed without metal without photosensitive in we The free radical cyclization of agent, perfluoroalkyl substituted benzimidazole and compound of isobioquin group are by being simply functionalized N- methyl It is prepared by the one pot reaction of acryloyl group -2-Phenylbenzimidazole and the perfluoroalkyl iodide being easy to get under mild reaction conditions.This is Realization for the first time prepares perfluoroalkyl substituted benzimidazole and compound of isobioquin group.
Summary of the invention
The invention proposes the preparation method of a kind of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, the conjunctions Mild at method reaction condition, handy and safe, raw material is cheap and easy to get, is a kind of environmental-friendly green synthesis method.
It realizes the technical scheme is that a kind of benzimidazole and compound of isobioquin group, structural formula are as follows:
,
Wherein, R1For methyl, methoxyl group, ethyl, chlorine, bromine, trifluoromethyl etc.;RfFor C4F9、C5F11,C10F21
The preparation method of the perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows: will be fragrant Base benzimidazoles compound and perfluoroalkyl iodide are dissolved in acetonitrile solvent, and TMEDA (tetraethyl diamines) illumination is then added Under reacted, after reaction, decompression boils off solvent, obtains perfluoroalkyl substituted benzimidazole and isoquinoline through column chromatography for separation Quinoline ketone compounds.
The structural formula of the N- methylacryloyl -2-Phenylbenzimidazole is as follows:
,
Wherein R1For methyl, methoxyl group, ethyl, chlorine, trifluoromethyl etc..
The preparation method of the perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows: by N- Methylacryloyl -2-Phenylbenzimidazole class compound and perfluoroalkyl iodide are dissolved in acetonitrile solvent, and TMEDA is then added It is reacted, after reaction, decompression boils off solvent, obtains benzimidazole and compound of isobioquin group through column chromatography for separation.
The structural formula of the perfluoroalkyl substituted benzimidazole and compound of isobioquin group is as follows:
,
Wherein, R1For methyl, methoxyl group, ethyl, chlorine, trifluoromethyl etc..RfFor C4F9、C5F11,C10F21,CF2COOEt etc..
The solvent is acetonitrile;
The aryl benzimidazole, perfluoroalkyl iodide, TMEDA molar ratio be 1:2:2.
The reaction temperature is 35 DEG C, and the reaction time is 12 h.
Reaction light source is 25 W LED light, and reaction carries out under nitrogen protection.
The reaction formula of preparation method of the present invention is as follows:
,
The beneficial effects of the present invention are: the present invention provides a kind of photocatalysis perfluoroalkyl substituted benzimidazole and isobioquin groups The preparation method of compound, the method mild condition, no metal are easy to operate, regioselectivity is high, yield without photosensitizer Height is conducive to industrialized production, and the synthesis for benzimidazole and compound of isobioquin group provides new method.
Specific embodiment
Below in conjunction with the embodiment of the present invention, technical solution of the present invention is clearly and completely described, it is clear that institute The embodiment of description is only a part of the embodiment of the present invention, instead of all the embodiments.Based on the embodiments of the present invention, Those of ordinary skill in the art's every other embodiment obtained under that premise of not paying creative labor, belongs to this hair The range of bright protection.
Embodiment 1
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2-Phenylbenzimidazole (0.2 mmol) is added in 25 mL reaction tubes, perfluor butyl iodide (0.4 mmol), TMEDA (tetraethyl diamines) (0.4 mmol), 2mL acetonitrile, nitrogen protection, the 25 W blue at 35 DEG C LEDs irradiation is lower to stir 12 h.After reaction, decompression boils off solvent, silica gel column chromatography separation, and the yield for obtaining final product is 76%。
Concrete outcome is as follows:
,
1H NMR (400 MHz, Chloroform-d) δ 8.53 (dd, J = 7.7, 1.5 Hz, 1H), 8.36 (m, 3.1 Hz, 1H), 7.84 (dd, J = 6.4, 2.6 Hz, 1H), 7.65 – 7.40 (m, 5H), 3.66 – 3.46 (m, 1H), 2.91 (m, 1H), 1.79 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 170.99, 149.26, 144.07, 138.67, 131.54, 131.43, 128.41, 126.52 (d, J = 2.7 Hz), 126.32, 126.14, 125.79, 122.25, 119.96, 115.76, 124.399 – 105.689 (m), 44.93 (d, J = 3.0 Hz), 40.14, 31.63. 19F NMR (376 MHz, Chloroform-d) δ -81.11 (d, J = 10.4 Hz, 3F), -107.84 (dd, J = 273.8, 14.7 Hz, 1F), -111.43 – -112.67 (m, 1F), -124.70 (s, 2F), -125.53 – -126.19 (m, 4F)。
Embodiment 2
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2-Phenylbenzimidazole (0.2 mmol) is added in 25 mL reaction tubes, perfluor iodo-pentane (0.4 mmol), TMEDA (0.4 mmol), 2mL acetonitrile, nitrogen protection stir under 25 W blue led s irradiation at 35 DEG C 12 h.After reaction, decompression boils off solvent, and silica gel column chromatography separation, the yield for obtaining final product is 80%.
The following concrete outcome of concrete outcome is as follows:
1H NMR (400 MHz, Chloroform-d) δ 8.54 (d, J = 7.9 Hz, 1H), 8.37 (d, J = 6.6 Hz, 1H), 7.85 (m, 1H), 7.66 – 7.40 (m, 5H), 3.55 (dd, J = 32.9, 15.2 Hz, 1H), 2.91 (m, 1H), 1.78 (s, 1H). 13C NMR (101 MHz, Chloroform-d) δ 170.98, 149.25, 144.09, 138.68, 131.52, 131.44, 128.38, 126.50 (d, J = 2.6 Hz), 126.32, 126.11, 125.77, 122.28, 119.96, 115.75, 121.83 – 104.99 (m), 44.95 (d, J = 3.0 Hz), 40.26 (t, J = 19.6 Hz), 31.58. 19F NMR (376 MHz, Chloroform-d) δ -80.88 (d, J = 10.2 Hz, 3F), -107.69 (m, 1F), -111.94 (m, 1F), -122.57 (m, 2F), -124.03 (t, J = 13.7 Hz, 2F), -125.90 – -126.95 (m, 2F)。
Embodiment 3
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2-Phenylbenzimidazole (0.2 mmol) is added in 25 mL reaction tubes, perfluor iodo certain herbaceous plants with big flowers alkane (0.4 mmol), TMEDA (0.4 mmol), 2mL acetonitrile, nitrogen protection stir under 25 W blue led s irradiation at 35 DEG C 12 h.After reaction, decompression boils off solvent, and silica gel column chromatography separation, the yield for obtaining final product is 64%.
Concrete outcome is as follows:
,
1H NMR (400 MHz, Chloroform-d) δ 8.54 (dd, J = 7.8, 1.5 Hz, 1H), 8.37 (dd, J = 6.7, 2.4 Hz, 1H), 7.85 (dd, J = 6.4, 2.3 Hz, 1H), 7.62 – 7.41 (m, 5H), 3.55 (dd, J = 32.9, 15.4 Hz, 1H), 2.91 (m, 1H), 1.78 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 170.98, 149.25, 144.07, 138.68, 131.54 (d, J = 5.9 Hz), 131.43, 128.42 (d, J = 5.8 Hz), 126.50 (d, J = 2.5 Hz), 126.35 (d, J = 5.7 Hz), 126.15 (d, J = 6.0 Hz), 125.81 (d, J = 5.9 Hz), 122.29 (d, J = 5.7 Hz), 119.98 (d, J = 5.7 Hz), 115.78 (d, J = 5.8 Hz), 118.50 – 107.74 (m), 44.95 (d, J = 3.0 Hz), 40.26 (t, J = 19.5 Hz), 31.65. 19F NMR (376 MHz, Chloroform-d) δ -80.90 (t, J = 10.1 Hz, 3F), -107.67 (m, 1F), -111.89 (m, 1F), -121.59 (s, 2F), -121.95 (d, J = 39.7 Hz, 8F), -122.83 (d, J = 17.3 Hz, 2F), -123.84 (d, J = 17.0 Hz, 2F), -126.22 (d, J = 14.7 Hz, 2F)。
Embodiment 4
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2- p-methylphenyl benzimidazole (0.2 mmol) is added in 25 mL reaction tubes, perfluor iodo fourth Alkane (0.4 mmol), TMEDA (0.4 mmol), 2 mL acetonitriles, nitrogen protection are stirred under 25 W blue led s irradiation at 35 DEG C Mix 12 h.After reaction, decompression boils off solvent, and silica gel column chromatography separation, the yield for obtaining final product is 73%.
Concrete outcome is as follows:
1H NMR (400 MHz, Chloroform-d) δ 8.41 (m, 1H), 8.36 (dd, J = 7.0, 2.7 Hz, 1H), 7.86 – 7.78 (m, 1H), 7.43 (m, 2H), 7.37 – 7.30 (m, 1H), 7.27 (d, J = 3.1 Hz, 1H), 3.54 (dd, J = 33.0, 15.5 Hz, 1H), 2.90 (m, 1H), 2.46 (t, J = 2.4 Hz, 3H), 1.77 (t, J = 2.4 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 171.14, 149.52, 144.14, 142.22, 138.72, 131.41, 129.49, 126.89 (d, J = 2.3 Hz), 126.22, 126.00, 125.49, 119.76, 119.60, 115.67, 121.84 – 105.34 (m), 44.87 (d, J = 2.9 Hz), 40.10 (t, J = 19.6 Hz), 31.57, 21.73. 19F NMR (376 MHz, Chloroform-d) δ -81.27 (t, J = 9.9 Hz, 3F), -108.00 (m. 1F), -112.32 (m, 1F), -124.83 (d, J = 13.1 Hz, 1F), -125.96 (dd, J = 17.9, 9.4 Hz, 2F), -126.07 (m, 2F)。
Embodiment 5
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2- p-methoxyphenyl benzimidazole (0.2 mmol) is added in 25 mL reaction tubes, perfluor iodine For butane (0.4 mmol), TMEDA (0.4 mmol), 2 mL acetonitriles, nitrogen protection, 25 W blue led s irradiate at 35 DEG C 12 h of lower stirring.After reaction, decompression boils off solvent, and silica gel column chromatography separation, the yield for obtaining final product is 72%.
Concrete outcome is as follows:
1H NMR (400 MHz, Chloroform-d) δ 8.47 (d, J = 8.8 Hz, 1H), 8.33 (dd, J = 7.5, 1.6 Hz, 1H), 7.84 – 7.74 (m, 1H), 7.42 (m, 2H), 7.08 (dd, J = 8.8, 2.4 Hz, 1H), 6.95 (d, J = 2.2 Hz, 1H), 3.92 (s, 3H), 3.63 – 3.44 (m, 1H), 2.95 – 2.76 (m, 1H), 1.77 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 170.95, 162.33, 149.42, 144.22, 140.75, 131.36, 128.29, 126.00, 125.27, 119.55, 115.60, 115.15, 113.93, 112.48 (d, J = 2.7 Hz), 121.51 – 108.41 (m), 55.61, 45.09 (d,J = 3.0 Hz), 40.22 (t, J = 19.8 Hz), 31.81. 19F NMR (376 MHz, Chloroform-d) δ -81.08 (t, J = 10.4 Hz, 3F), -107.79 (d, J = 274.3 Hz, 1F), -112.15 (d, J = 274.5 Hz, 1F), -124.67 (s, 2F), -125.89 (m, 2F)。
Embodiment 6
The preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2- is added in 25 mL reaction tubes to ethylphenyl benzimidazole (0.2 mmol), perfluor iodo Butane (0.4 mmol), TMEDA (0.4 mmol), 2 mL acetonitriles, nitrogen protection, at 35 DEG C under 25 W blue led s irradiation Stir 12 h.After reaction, decompression boils off solvent, and silica gel column chromatography separation, the yield for obtaining final product is 72%.
Concrete outcome is as follows:
1H NMR (400 MHz, Chloroform-d) δ 8.44 (d, J = 8.1 Hz, 1H), 8.39 – 8.31 (m, 1H), 7.86 – 7.78 (m, 1H), 7.48 – 7.34 (m, 3H), 7.28 (s, 1H), 3.64 – 3.44 (m, 1H), 2.92 (m, 1H), 2.76 (q, J = 7.6 Hz, 2H), 1.77 (s, 3H), 1.29 (t, J = 7.6 Hz, 3H). 13C NMR (101 MHz, Chloroform-d) δ 171.19, 149.52, 148.45, 144.15, 138.74, 131.40, 128.31, 126.38, 126.04, 125.82 (d, J = 2.4 Hz), 125.52, 119.78, 115.69, 121.51 – 108.41 (m), 44.99 (d, J = 3.1 Hz), 40.07 (t, J = 19.6 Hz), 31.74, 29.18, 15.27. 19F NMR (376 MHz, Chloroform-d) δ -81.13 (t, J = 9.7 Hz, 3F), -107.83 (m,1F), -112.15 (m,1F), -124.77 (q, J = 11.0, 10.1 Hz, 2F), -125.73 – -126.14 (m, 2F)。
Embodiment 7
The preparation method of benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2- rubigan benzimidazole (0.2 mmol) is added in 25 mL reaction tubes, other test sides With embodiment 1, concrete outcome is as follows for method and condition:
1H NMR (400 MHz, Chloroform-d) δ 8.47 (d, J = 8.5 Hz, 1H), 8.38 – 8.31 (m, 1H), 7.86 – 7.80 (m, 1H), 7.54 – 7.42 (m, 4H), 3.65 – 3.46 (m, 1H), 2.86 (m, 1H), 1.79 (s, 3H). 13C NMR (101 MHz, Chloroform-d) δ 170.26, 148.31, 143.98, 140.30, 137.84, 131.35, 129.08, 127.71, 126.75 (d, J = 2.3 Hz), 126.30, 126.04, 120.91, 120.04, 115.74, 121.79 – 105.66 (m), 44.93 (d, J = 3.0 Hz), 40.22 (t, J = 19.7 Hz), 31.41. 19F NMR (376 MHz, Chloroform-d) δ - 81.19 (d, J = 10.6 Hz, 3F), -107.69 (m,1F), -112.19 (m, 1F), -124.70 (d, J = 11.5 Hz, 2F), -125.99 (m, 2F)。
Embodiment 8
The preparation method of benzimidazole and compound of isobioquin group, steps are as follows:
N- methylacryloyl -2- p-trifluoromethyl phenyl benzimidazole (0.2 mmol) is added in 25 mL reaction tubes, other With embodiment 1, concrete outcome is as follows for test method and condition:
1H NMR (400 MHz, Chloroform-d) δ 8.67 (d, J = 8.2 Hz, 1H), 8.44 – 8.32 (m, 1H), 7.95 – 7.83 (m, 1H), 7.79 (dd, J = 8.3, 1.6 Hz, 1H), 7.73 (s, 1H), 7.55 – 7.44 (m, 2H), 3.70 – 3.52 (m, 1H), 3.03 – 2.85 (m, 1H), 1.83 (s, 3H).13C NMR (101 MHz, Chloroform-d) δ 170.11, 147.69, 143.96, 139.24, 133.19 (q, J = 32.9 Hz), 131.40, 127.02, 126.50 (d, J = 4.4 Hz), 125.54, 125.27 (q, J = 3.6 Hz), 124.82, 123.67 (q, J = 3.9 Hz), 122.12, 120.37, 115.86, 121.44 – 109.76 (m), 45.12 (d, J = 3.3 Hz), 40.22 (t, J = 19.8 Hz), 31.41. 19F NMR (376 MHz, Chloroform-d) δ -59.59 – -70.61 (m, 3F), -81.22 (d, J = 10.5 Hz, 3F), - 107.51 (d, J = 274.4 Hz, 1F), -111.93 (d, J = 273.7 Hz, 1F), -124.34 – - 126.62 (m, 4F)。
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all in essence of the invention Within mind and principle, any modification, equivalent replacement, improvement and so on be should all be included in the protection scope of the present invention.

Claims (6)

1. a kind of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, it is characterised in that structural formula is as follows:
,
Wherein, R1For methyl, methoxyl group, ethyl, chlorine, bromine, trifluoromethyl etc.;RfFor C4F9、C5F11, C10F21
2. the preparation method of perfluoroalkyl substituted benzimidazole and compound of isobioquin group, it is characterised in that steps are as follows: will N- methylacryloyl -2-Phenylbenzimidazole class compound and perfluoroalkyl iodide are dissolved in acetonitrile solvent, are then added It is reacted under TMEDA (tetraethyl diamines) illumination, after reaction, decompression boils off solvent, obtains perfluor through column chromatography for separation Alkyl substituted benzene and imidazo compound of isobioquin group.
3. the preparation method of perfluoroalkyl substituted benzimidazole according to claim 2 and compound of isobioquin group, It is characterized in that the N- methylacryloyl -2-Phenylbenzimidazole class compound structural formula is as follows:
,
Wherein R1For R1For methyl, methoxyl group, ethyl, chlorine, bromine, trifluoromethyl etc..
4. the preparation method of perfluoroalkyl substituted benzimidazole according to claim 2 and compound of isobioquin group, Be characterized in that: the solvent is acetonitrile.
5. the preparation method of perfluoroalkyl substituted benzimidazole according to claim 2 and compound of isobioquin group, It is characterized in that: the N- methylacryloyl -2-Phenylbenzimidazole class compound, perfluoroalkyl iodide, TMEDA (tetraethyl two Amine) molar ratio be 1:2:2.
6. the preparation method of perfluoroalkyl substituted benzimidazole according to claim 2 and compound of isobioquin group, Be characterized in that: the reaction temperature is 35 DEG C, and the reaction time is 12 h, nitrogen protection, the irradiation of 25 w blue LED lamps.
CN201910507221.0A 2019-06-12 2019-06-12 Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof Pending CN110078737A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910507221.0A CN110078737A (en) 2019-06-12 2019-06-12 Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910507221.0A CN110078737A (en) 2019-06-12 2019-06-12 Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof

Publications (1)

Publication Number Publication Date
CN110078737A true CN110078737A (en) 2019-08-02

Family

ID=67424138

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910507221.0A Pending CN110078737A (en) 2019-06-12 2019-06-12 Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof

Country Status (1)

Country Link
CN (1) CN110078737A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112851670A (en) * 2021-01-19 2021-05-28 深圳大学 Simple synthesis method of 3-polyfluoroalkyl substituted imidazo [1,2-a ] pyridine
CN113373465A (en) * 2021-05-13 2021-09-10 北京工业大学 Method for synthesizing silicon-based substituted benzimidazolo isoquinolinone compounds through photoelectric concerted catalysis
CN114105981A (en) * 2021-12-14 2022-03-01 怀化学院 Method for preparing benzimidazole [2,1-a ] isoquinoline-6 (5H) -ketone compound
CN116157402A (en) * 2020-08-06 2023-05-23 默克专利有限公司 Material for organic electroluminescent device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150037712A (en) * 2013-09-30 2015-04-08 주식회사 엘지화학 Heterocyclic compound and organic light emitting device comprising the same
CN109824666A (en) * 2019-03-19 2019-05-31 青岛农业大学 The synthetic method and products therefrom of isoquinoline compound

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20150037712A (en) * 2013-09-30 2015-04-08 주식회사 엘지화학 Heterocyclic compound and organic light emitting device comprising the same
CN109824666A (en) * 2019-03-19 2019-05-31 青岛农业大学 The synthetic method and products therefrom of isoquinoline compound

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116157402A (en) * 2020-08-06 2023-05-23 默克专利有限公司 Material for organic electroluminescent device
CN112851670A (en) * 2021-01-19 2021-05-28 深圳大学 Simple synthesis method of 3-polyfluoroalkyl substituted imidazo [1,2-a ] pyridine
CN113373465A (en) * 2021-05-13 2021-09-10 北京工业大学 Method for synthesizing silicon-based substituted benzimidazolo isoquinolinone compounds through photoelectric concerted catalysis
CN114105981A (en) * 2021-12-14 2022-03-01 怀化学院 Method for preparing benzimidazole [2,1-a ] isoquinoline-6 (5H) -ketone compound

Similar Documents

Publication Publication Date Title
CN110078737A (en) Perfluoroalkyl substituted benzimidazole and compound of isobioquin group and preparation method thereof
Pan et al. Recent advances in photoinduced trifluoromethylation and difluoroalkylation
CN107141248A (en) A kind of method that visible light catalytic synthesizes the ketene compound of 3 sulfuryl loop coil three
CN110066279A (en) Perfluoroalkyl substituted indole and isoquinoline compound and preparation method thereof
CN103992225B (en) A kind of salicylaldehyde derivatives and preparation method thereof
CA3122627A1 (en) Improvements in or relating to organic material
CN109053625A (en) A kind of preparation method replacing benzothiazole C2 alkyl derivative
Wang et al. One-pot synthesis of 3-fluoroflavones via 1-(2-hydroxyphenyl)-3-phenylpropane-1, 3-diones and selectfluor at room temperature
CN107188832A (en) A kind of method that utilization carbon dioxide synthesizes the carbamate containing trifluoromethyl
CN111423394B (en) Synthesis method of 1,3, 4-oxadiazole heterocyclic compound
CN106892800A (en) A kind of preparation method and application of unactivated alkene hydrogen trifluoromethylation
CN107522584B (en) Alpha-trifluoromethyl ketone compound and preparation method thereof
CN109574906A (en) A kind of preparation method of 3,3 '-two Indoleacetic esters
CN104496909B (en) A kind of double-core benzimidazole ion salt and its preparation method and application
CN104447336B (en) A kind of three dish ene derivatives and preparation method thereof
CN102675241A (en) Method for synthesizing multi-substituted benzothiazole derivative
CN111072605A (en) Preparation method of fluoroalkyl-substituted benzofuran derivative or indole derivative
CN117304094A (en) Synthesis method of 3-trifluoromethyl pyridine or 3-difluoro methyl pyridine compound
CN102199154A (en) Novel synthesis method for pyrrole derivatives
CN102796003B (en) Preparation method of 2-fluoro-4,5-dichloronitrobenzene
CN114075108A (en) Deuteration of aldehyde and application in preparing deuteration aldehyde
CN106083690A (en) A kind of preparation method of polysubstituted 3 methylene indolones
CN110156675A (en) The synthetic method of quinolines containing sulfonyl
CN104710305B (en) A kind of synthetic method of 2-(2-hydroxy phenyl)-2-fluoroacetic acid ester
CN112441935B (en) Synthesis method of beta-aminoketone compound

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190802